Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
IE |
|
Maps SpA
MIL:MAPS
|
IT |
|
Enseval Putera Megatrading Tbk PT
IDX:EPMT
|
ID |
|
Hiab Oyj
F:C1C1
|
FI |
|
Levi Strauss & Co
NYSE:LEVI
|
US |
|
D
|
Daya Intiguna Yasa Tbk PT
IDX:MDIY
|
ID |
|
Comstock Inc
F:GSP
|
US |
|
F
|
First Tractor Co Ltd
OTC:FIRRF
|
CN |
|
eXeBlock Technology Corp
OTC:EXXBF
|
CA |
Wall St Price Targets
JAZZ Price Targets Summary
Jazz Pharmaceuticals PLC
According to Wall Street analysts, the average 1-year price target for JAZZ is 247.51 USD with a low forecast of 189.88 USD and a high forecast of 295.05 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is JAZZ's stock price target?
Price Target
247.51
USD
According to Wall Street analysts, the average 1-year price target for JAZZ is 247.51 USD with a low forecast of 189.88 USD and a high forecast of 295.05 USD.
What is the Revenue forecast for Jazz Pharmaceuticals PLC?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Jazz Pharmaceuticals PLC?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 8 years is 22%.
